Form D · Biotechnology

Gyroscope Therapeutics Ltd

Stevenage, Hertfordshire, X0 · CIK 0001832123

Offering snapshot reported Apr 15, 2021 · SEC filing

Reported sold
$148M
Offering amount: $148M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 15, 2021Initial$148,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-395903

Source: Form D, filed Apr 15, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sean Bohen Director
Ian Clark Director
Jennifer Cook Director
Khurem Farooq Executive
David Fellows Director
Renee Gala Director
Chris Hollowood Director
Jane Hughes Executive
Wouter Joustra Director
Maha Katabi Director
Edward Lang Executive
Ian Pitfield Executive
Jessica Stitt Executive
Nadia Waheed Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Stevenage Bioscience Catalyst Gunnels Wood Road
Stevenage, Hertfordshire, X0, SG1 2FX